Sarcopenia is Associated with Chemotherapy Toxicity in Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis from Colorectal Cancer

Sarcopenia is associated with an increased inflammatory response to surgery in colorectal cancer

(2016) Kostan W. Reisinger et al.   CLINICAL NUTRITION

Functional Compromise Reflected by Sarcopenia, Frailty, and Nutritional Depletion Predicts Adverse Postoperative Outcome After Colorectal Cancer Surgery

(2015) Kostan W. Reisinger et al.   ANNALS OF SURGERY

Skeletal Muscle Depletion is Associated with Severe Postoperative Complications in Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis of Colorectal Cancer

(2015) Jeroen L. A. van Vugt et al.   ANNALS OF SURGICAL ONCOLOGY

Malnutrition risk predicts surgical outcomes in patients undergoing gastrointestinal operations: Results of a prospective study

(2015) Judy W.C. Ho et al.   CLINICAL NUTRITION

The Impact of Open Versus Laparoscopic Resection for Colon Cancer on C-Reactive Protein Concentrations as a Predictor of Postoperative Infective Complications

(2014) Michelle L. Ramanathan et al.   ANNALS OF SURGICAL ONCOLOGY

Pre-operative Assessment of Muscle Mass to Predict Surgical Complications and Prognosis in Patients With Endometrial Cancer

(2014) L. M. Kuroki et al.   ANNALS OF SURGICAL ONCOLOGY

Merits of exercise therapy before and after major surgery

(2014) Thomas J. Hoogeboom et al.   Current Opinion in Anesthesiology

Sarcopenia Is Linked to Treatment Toxicity in Patients With Metastatic Colorectal Cancer

(2014) Maximilien Barret et al.   NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL

Effect of muscle mass on toxicity and survival in patients with colon cancer undergoing adjuvant chemotherapy

(2014) Hee-Won Jung et al.   SUPPORTIVE CARE IN CANCER

Bevacizumab Doubles the Early Postoperative Complication Rate after Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Peritoneal Carcinomatosis of Colorectal Origin

(2013) Clarisse Eveno et al.   ANNALS OF SURGICAL ONCOLOGY

Sarcopenia and body mass index predict sunitinib-induced early dose-limiting toxicities in renal cancer patients

(2013) O Huillard et al.   BRITISH JOURNAL OF CANCER

Body Composition Variation and Impact of Low Skeletal Muscle Mass in Patients With Advanced Medullary Thyroid Carcinoma Treated With Vandetanib: Results From a Placebo-Controlled Study

(2013) Marie-Hélène Massicotte et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Cancer Cachexia in the Age of Obesity: Skeletal Muscle Depletion Is a Powerful Prognostic Factor, Independent of Body Mass Index

(2013) Lisa Martin et al.   JOURNAL OF CLINICAL ONCOLOGY

Analytic morphometric assessment of patients undergoing colectomy for colon cancer

(2013) Michael S. Sabel et al.   JOURNAL OF SURGICAL ONCOLOGY

Interpreting the concordance statistic of a logistic regression model: relation to the variance and odds ratio of a continuous explanatory variable

(2012) Peter C Austin et al.   BMC Medical Research Methodology

Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration

(2012) Douglas G Altman et al.   BMC Medicine

Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery

(2012) J R Lieffers et al.   BRITISH JOURNAL OF CANCER

Sarcopenia Predicts Early Dose-Limiting Toxicities and Pharmacokinetics of Sorafenib in Patients with Hepatocellular Carcinoma

(2012) Olivier Mir et al.   PLoS One

Treatment of Colorectal Peritoneal Carcinomatosis With Systemic Chemotherapy: A Pooled Analysis of North Central Cancer Treatment Group Phase III Trials N9741 and N9841

(2011) Jan Franko et al.   JOURNAL OF CLINICAL ONCOLOGY

Sarcopenia negatively impacts short-term outcomes in patients undergoing hepatic resection for colorectal liver metastasis

(2011) Peter D. Peng et al.   HPB

Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinoma

(2010) S. Antoun et al.   ANNALS OF ONCOLOGY

Should the Treatment of Peritoneal Carcinomatosis by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Still be Regarded as a Highly Morbid Procedure?

(2009) Terence C. Chua et al.   ANNALS OF SURGERY

A Systematic Review and Meta-Analysis of Cytoreductive Surgery with Perioperative Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis of Colorectal Origin

(2009) Christopher Cao et al.   ANNALS OF SURGICAL ONCOLOGY

Nutritional Risk Factors in Planned Oncologic Surgery: What Clinical and Biological Parameters Should Be Routinely Used?

(2009) Sami Antoun et al.   WORLD JOURNAL OF SURGERY

A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care

(2008) Marina Mourtzakis et al.   Applied Physiology Nutrition and Metabolism

Complete Cytoreductive Surgery Plus Intraperitoneal Chemohyperthermia With Oxaliplatin for Peritoneal Carcinomatosis of Colorectal Origin

(2008) Dominique Elias et al.   JOURNAL OF CLINICAL ONCOLOGY